BioCardia, Inc. SEC filings BCDA
BioCardia, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Sep 27, 2007. Its latest annual report, Form 10-K, was filed on Mar 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 19, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Other events
|
Oct 7, 2026 | Oct 7, 2026 |
| 8-K |
Current report
Other events
|
Oct 1, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Other events
|
Sep 23, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Other events
|
Sep 21, 2026 | Sep 21, 2026 |
| 8-K |
Current report
Other events
|
Sep 10, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 24, 2026 | Aug 24, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 21, 2026 | Aug 19, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Listing notice
|
Jun 12, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Other events
|
Jun 8, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 5, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 28, 2026 | May 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 21, 2026 | May 21, 2026 |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 8, 2026 | May 8, 2026 |
| 8-K |
Current report
Other events
|
Apr 28, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 20, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Listing notice
|
Apr 15, 2026 | Apr 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 2, 2026 | Apr 2, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2026 | Mar 24, 2026 |
| S-8 | Employee stock plan registration | Mar 24, 2026 | — |
| 10-K | Annual report | Mar 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 17, 2026 | Mar 17, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 3, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Other events
|
Feb 10, 2026 | Feb 10, 2026 |
| 8-K |
Current report
Other events
|
Feb 3, 2026 | Feb 3, 2026 |
| S-8 | Employee stock plan registration | Dec 18, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 16, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Dec 3, 2025 | Dec 2, 2025 |
| 8-K |
Current report
Other events
|
Nov 24, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Other events
|
Nov 10, 2025 | Nov 10, 2025 |
| DEF 14A | Proxy statement | Nov 3, 2025 | Dec 2, 2025 |
| 8-K |
Current report
Other events
|
Oct 30, 2025 | Oct 30, 2025 |
| 10-Q/A | Amended quarterly report | Oct 29, 2025 | Jun 30, 2025 |
| 424B5 | Prospectus supplement | Oct 24, 2025 | — |
| 8-K | Current report | Oct 7, 2025 | Oct 7, 2025 |
| 8-K |
Current report
Other events
|
Oct 2, 2025 | Oct 2, 2025 |
| 8-K |
Current report
Listing notice
|
Sep 24, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Other events
|
Sep 22, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Other events
|
Sep 19, 2025 | Sep 19, 2025 |
| 424B4 | Prospectus | Sep 19, 2025 | — |
| EFFECT | Filing | Sep 18, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 18, 2025 | Sep 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 18, 2025 | Sep 18, 2025 |
| CORRESP | Letter to the SEC | Sep 17, 2025 | — |
| S-1/A | Amended registration statement | Sep 17, 2025 | — |
| CORRESP | Letter to the SEC | Sep 16, 2025 | — |
| S-1 | Registration statement | Sep 16, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 13, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Other events
|
Aug 4, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Other events
|
Jul 24, 2025 | Jul 24, 2025 |
| EFFECT | Filing | Jul 17, 2025 | — |
| EFFECT | Filing | Jul 17, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 16, 2025 | Jul 16, 2025 |
| CORRESP | Letter to the SEC | Jul 15, 2025 | — |
| CORRESP | Letter to the SEC | Jul 15, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2025 | — |
| S-3 | Shelf registration | Jul 9, 2025 | — |
| 424B5 | Prospectus supplement | Jul 8, 2025 | — |
| 8-K |
Current report
Unregistered share sale, Other events
|
Jul 2, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Jun 25, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
May 6, 2025 | May 6, 2025 |
| UPLOAD | Letter from the SEC | May 5, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 1, 2025 | Apr 30, 2025 |
| S-3 | Shelf registration | Apr 30, 2025 | — |
| 8-K |
Current report
Unregistered share sale, Other events
|
Apr 23, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 15, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Other events
|
Apr 11, 2025 | Apr 11, 2025 |
| 424B5 | Prospectus supplement | Apr 4, 2025 | — |
| 8-K |
Current report
Listing notice
|
Apr 4, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 31, 2025 | Mar 31, 2025 |
| S-8 | Employee stock plan registration | Mar 26, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 26, 2025 | Mar 26, 2025 |
| 10-K | Annual report | Mar 26, 2025 | Dec 31, 2024 |
| UPLOAD | Letter from the SEC | Mar 20, 2025 | — |
| DRS | Filing | Mar 17, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Other events
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Other events
|
Feb 13, 2025 | Feb 13, 2025 |
| 8-K |
Current report
Other events
|
Jan 27, 2025 | Jan 27, 2025 |
| 8-K |
Current report
Other events
|
Dec 17, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Other events
|
Dec 4, 2024 | Dec 4, 2024 |
| 424B5 | Prospectus supplement | Dec 2, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Oct 28, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Other events
|
Sep 18, 2024 | Sep 18, 2024 |
| 8-K |
Current report
Other events
|
Sep 9, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Other events
|
Sep 3, 2024 | Aug 29, 2024 |
| 424B4 | Prospectus | Aug 30, 2024 | — |
| 424B4 | Prospectus | Aug 30, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 30, 2024 | Aug 30, 2024 |
| EFFECT | Filing | Aug 29, 2024 | — |
| S-1MEF | Form s-1mef | Aug 29, 2024 | — |
| CORRESP | Letter to the SEC | Aug 29, 2024 | — |
| CORRESP | Letter to the SEC | Aug 29, 2024 | — |
| S-1/A | Amended registration statement | Aug 29, 2024 | — |
| 8-K |
Current report
Other events
|
Aug 28, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 21, 2024 | Aug 21, 2024 |
| UPLOAD | Letter from the SEC | Aug 16, 2024 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| S-1 | Registration statement | Aug 9, 2024 | — |
| 25-NSE | Delisting notice | Aug 2, 2024 | — |
| 8-K |
Current report
Other events
|
Jul 30, 2024 | Jul 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 25, 2024 | Jul 25, 2024 |
| 8-K |
Current report
Other events
|
Jul 17, 2024 | Jul 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 8, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Other events
|
Jun 10, 2024 | Jun 10, 2024 |
| 8-K |
Current report
Other events
|
Jun 7, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
May 30, 2024 | May 29, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
May 21, 2024 | May 20, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 1, 2024 | May 1, 2024 |
| DEF 14A | Proxy statement | Apr 15, 2024 | May 20, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2024 | May 20, 2024 |
| EFFECT | Filing | Apr 1, 2024 | — |
| CORRESP | Letter to the SEC | Mar 28, 2024 | — |
| S-8 | Employee stock plan registration | Mar 27, 2024 | — |
| 8-K |
Current report
Results of operations
|
Mar 27, 2024 | Mar 27, 2024 |
| 10-K | Annual report | Mar 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Listing notice
|
Mar 12, 2024 | Mar 6, 2024 |
| 8-K |
Current report
Other events
|
Mar 12, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| UPLOAD | Letter from the SEC | Feb 16, 2024 | — |
| S-3 | Shelf registration | Feb 14, 2024 | — |
| 8-K |
Current report
Unregistered share sale, Other events
|
Feb 9, 2024 | Feb 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 8, 2024 | Feb 8, 2024 |
| 8-K |
Current report
Other events
|
Jan 31, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Other events
|
Dec 19, 2023 | Dec 19, 2023 |
| 8-K |
Current report
Other events
|
Dec 18, 2023 | Dec 18, 2023 |
| 8-K |
Current report
Other events
|
Dec 6, 2023 | Dec 6, 2023 |
| 424B5 | Prospectus supplement | Dec 6, 2023 | — |
| EFFECT | Filing | Dec 5, 2023 | — |
| 8-K/A |
Amended current report
Shareholder vote results
|
Dec 5, 2023 | Oct 18, 2023 |
| 8-K | Current report | Dec 5, 2023 | Dec 5, 2023 |
| CORRESP | Letter to the SEC | Dec 1, 2023 | — |
| 8-K |
Current report
Other events
|
Nov 29, 2023 | Nov 29, 2023 |
| 424B5 | Prospectus supplement | Nov 17, 2023 | — |
| 8-K |
Current report
Other events
|
Nov 16, 2023 | Nov 16, 2023 |
| CORRESP | Letter to the SEC | Nov 15, 2023 | — |
| CORRESP | Letter to the SEC | Nov 14, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| UPLOAD | Letter from the SEC | Oct 24, 2023 | — |
| S-3 | Shelf registration | Oct 19, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Oct 18, 2023 | Oct 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 11, 2023 | Oct 11, 2023 |
| 8-K |
Current report
Listing notice
|
Sep 15, 2023 | Sep 13, 2023 |
| 8-K |
Current report
Listing notice
|
Sep 12, 2023 | Sep 6, 2023 |
| ARS | Annual report to shareholders | Sep 8, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 6, 2023 | Sep 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 5, 2023 | Sep 5, 2023 |
| DEF 14A | Proxy statement | Sep 1, 2023 | Oct 18, 2023 |
| 8-K | Current report | Aug 21, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 24, 2023 | Jul 24, 2023 |
| 8-K |
Current report
Other events
|
Jul 5, 2023 | Jul 5, 2023 |
| 8-K |
Current report
Agreement ended, Other events
|
Jun 30, 2023 | Jun 30, 2023 |
| 424B5 | Prospectus supplement | Jun 22, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Other events
|
Jun 20, 2023 | Jun 20, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 20, 2023 | Jun 20, 2023 |
| 8-K |
Current report
Other events
|
Jun 8, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 23, 2023 | May 23, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Other events
|
May 9, 2023 | May 9, 2023 |
| 10-K/A | Amended annual report | May 1, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 1, 2023 | Apr 30, 2023 |
| 8-K |
Current report
Other events
|
Apr 28, 2023 | Apr 26, 2023 |
| 8-K |
Current report
Other events
|
Apr 4, 2023 | Apr 4, 2023 |
| S-8 | Employee stock plan registration | Mar 30, 2023 | — |
| 8-K |
Current report
Results of operations
|
Mar 29, 2023 | Mar 29, 2023 |
| 10-K | Annual report | Mar 29, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 6, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 1, 2023 | Feb 1, 2023 |
| EFFECT | Filing | Dec 22, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 22, 2022 | Dec 22, 2022 |
| CORRESP | Letter to the SEC | Dec 20, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2022 | — |
| S-3 | Shelf registration | Dec 19, 2022 | — |
| 8-K |
Current report
Unregistered share sale, Other events
|
Dec 15, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Other events
|
Dec 6, 2022 | Dec 6, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BCDA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Sunnyvale, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 925741
- Former names
- Tiger X Medical, Inc. (until Oct 17, 2016); Cardo Medical, Inc. (until May 25, 2011); CLICKNSETTLE COM INC (until Oct 20, 2008); NAM CORP (until Mar 29, 2000)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.